Effect of hepatic impairment on the pharmacokinetics, pharmacodynamics and tolerability of rivaroxaban - an oral, direct Factor Xa inhibitor. J Thromb Haemost - Halabi, A; Kubitza, D; Zuehlsdorf, M (2007)
(Suppl 2): Abstract P-M-635.